Compound Detail
CHEMBL647
APRACLONIDINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL647 |
| Name | APRACLONIDINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IEJXVRYNEISIKR-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
5
Targets
7
Activities
3
Assay Types
0
PK Parameters
15
Publications
3
Known Names
2
Indications
Molecular Properties
245.1
MW (Da)
1.76
ALogP
2
HBA
3
HBD
62.4
PSA (Ų)
0.66
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1987 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Glaucoma Myasthenia Gravis
ATC Classification
S01EA03
apraclonidine
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Activity Summary
Ki 4 meas. best 8.54
EC50 2 meas. best 8.72
IC50 1 meas. best 8.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adrenergic receptor alpha-2 CHEMBL2095158 | EC50 | 8.72 | 8.72 | 1.9 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 8.54 | 8.54 | 2.9 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2095158 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL266 | Ki | 8.32 | 8.32 | 4.8 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 7.52 | 7.52 | 30.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | EC50 | 6.75 | 6.75 | 180.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Ki | 6.75 | 6.75 | 180.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 8784451 | 10.1021/jm960359r | Adrenergic receptor alpha-1 | 2 |
| 2896247 | 10.1021/jm00400a009 | Rattus norvegicus | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 8784451 | 10.1021/jm960359r | Alpha-2A adrenergic receptor | 1 |
| 8784451 | 10.1021/jm960359r | Alpha-2B adrenergic receptor | 1 |
| 8784451 | 10.1021/jm960359r | Alpha-2C adrenergic receptor | 1 |
| 8784451 | 10.1021/jm960359r | Adrenergic receptor alpha-2 | 1 |
| 6094812 | 10.1021/jm00378a021 | ADMET | 1 |
| 3037080 | 10.1021/jm00390a021 | Adrenergic receptor alpha-2 | 1 |
| 2567783 | 10.1021/jm00127a037 | Adrenergic receptor alpha-2 | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine